Curelab Oncology
Dedham, US · Founded 2019 · Delaware corporation
Find your way into Curelab Oncology
25 people in our graph share verified history with the Curelab Oncology team — schools, employers, funds. One of them is your warm intro.
David Sinclairunlockedknows Alexander Shneider · together at Aging (overlapped)
×2knows the team · via Gen3 Partners (at the moment, Invention Machine, Inc.)
×2knows the team · via Boston University School of Public Health
×7knows the team · via Roskilde University
Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.
Founders & leadership
Curelab Oncology was founded in 2019 by Alexander Shneider.
AS

Alexander ShneiderFounder & CEO, BoD ChairmanAlexander Shneider is a biotech entrepreneur with over two decades of industry experience in drug development, R&D, and licensing. He holds professor-level positions at international universities and serves on editorial boards for scientific journals.
VG

Vlad GabaiVP of R&D
CL

Charles LeggCOO
JP
Jason PayneNamed on SEC filing
Board
AM

Anatoli MeriinBoard director
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2022
▶$3MraisedDec 2022 · 1 investors · BiotechnologyRule 506(b)
▶$3MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles LeggExecutive Officer
- Alex ShneiderExecutive Officer
- Jason PayneExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $10K
- Proceeds to insiders
- $100K
- First sale
- Aug 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Curelab Oncology do?
- Curelab Oncology develops anti-cancer drugs with a focus on gene therapy and immuno-oncology, taking programs from early discovery through clinical development. It is a biotech company operating in the oncology drug development space.
- Who founded Curelab Oncology?
- Curelab Oncology was founded by Alexander Shneider in 2019.
- How much funding has Curelab Oncology raised?
- Curelab Oncology has disclosed $3M raised across 1 round.
- Where is Curelab Oncology headquartered?
- Curelab Oncology is headquartered in Dedham, US.

